Bristol-Myers Squibb
Industry
Pharmaceuticals
Corporate Headquarters
Princeton, NJ
Corporate Profits, 2005-2024
$61.7 billion
Find an oligarch
Spending Snapshot
Campaign Spending
$17.0million
From Employees: 0.1%
Lobbying Spending
$5.0million
Total Political Spending
$22.0million
Issues
- Spent $7.9 million to oppose Prop. 79 (Defeated, 2005) (and support the competing Prop. 78 (Defeated, 2005)) to prevent the reduction of prescription drug prices
- Spent $6.3 million to oppose Prop. 61 (Defeated, 2016), which would have reduced prescription drug prices
- Lobbied against bills that sought to ensure the safety, effectiveness, and affordability of prescription drugs, including: AB-2690 (Defeated, 2007-08), AB-463 (Defeated, 2015-16),
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.3 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
Republicans
$18.9k
Democrats
$97.6k
Total - All Current Elected Officials
$116.6k
Pharmaceutical Research and Manufacturers of America California Initiative Fund: OPPOSED: PROP 79 - PRESCRIPTION DRUG DISCOUNTS. STATE-NEGOTIATED REBATES. | SUPPORTED: PROP 78 - PRESCRIPTION DRUGS. DISCOUNTS.
$7.9 million
No on Prop 61 - Californians Against the Deceptive Rx Proposition, a Coalition of Veterans Doctors Patient Advocates Seniors Taxpayers and Members of Pharmaceutical Research and Manufacturers of America: OPPOSED: PROPOSITION 061- STATE PRESCRIPTION DRUG PURCHASES. PRICING STANDARDS.
$6.3 million
Pharmaceutical Research and Manufacturers of America IEC
$1.1 million
California Republican Party
$337.1k
Pharmaceutical Research and Manufacturers Association of America PAC
$165.4k
